Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany
Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under…
23/02/2018 - 3 minutes
AiCuris
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
18/12/2017 - 9 minutes
World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance
This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of…
13/11/2017 - 3 minutes
Potential Herpes Cure from Germany Fast-Tracked for Patients with Weak Immune Systems
AiCuris' Pritelivir has now secured FDA endorsement in the form of a Fast Track Designation…
01/08/2017 - 2 minutes
Rise of the Superbugs: How is Biotech Fighting Antibiotic Resistance?
Fewer antibiotics are produced as development costs rise. We reached out to a few companies…
09/05/2017 - 8 minutes
This Herpes Cure is Proving to Work Better than its Predecessors
AiCuris' candidate pritelivir has shown to perform better than current standard antiviral treatments against genital…
17/01/2017 - 2 minutes
Cold Sore Cure Company enters the Antibiotic Resistance fight
AiCuris is developing a new antibiotic that might bring hope for patients in which all…
04/01/2017 - 2 minutes
German Record-deal Antiviral drug Succeeds in Phase III
AiCuris' Letermovir succeeds in Phase III after being licensed to MSD in a record €442.5M deal. It acts on a…
20/10/2016 - 2 minutes
Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure
Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of…
09/05/2016 - 2 minutes
Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO
AiCuris is a Biotech company based on the Bayer Life Sciences park in Wuppertal (Germany).…
15/02/2016 - 4 minutes
